Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Tirzepatide represents a dual-action GLP-1 and GIP receptor agonist that requires careful dose escalation to achieve optimal weight loss and metabolic outcomes
Warnings You should not use Tresiba if you are having an episode of hypoglycemia (low blood sugar)
The mean percentage change in weight at week 72 was 15.0% (95% confidence interval [CI], 15.9 to 14.2) with 5-mg weekly doses of tirzepatide, 19.5% (95% CI, 20.4 to 18.5) with 10-mg doses, and 20.9% (95% CI, 21.8 to 19.9) with 15-mg doses
The amount of noise, stimulation, and stress we navigate each day
Clinical evidence suggests that combining both agents may produce additive benefits for weight loss and A1C reduction in patients with type 2 diabetes or metabolic syndrome
Eat in smaller portions and increase your physical activity for optimal digestion
